IP Library Granted Patent US 9,345,653
Granted Patent B2
US 9,345,653 · App. 14/411,841 · Granted May 24, 2016

Dye composition comprising a cationic meta-phenylenediamine

Inventor: Aziz Fadli (Chelles, FR)
Assignee: L'OREAL
A61K8/494A61Q5/10C07D233/61C07D295/037
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,345,653
App. No.
14/411,841
Granted
May 24, 2016
Kind
B2
Abstract

One subject of the invention is a meia-phenylenediamine compound having formula (I) below, the addition salts thereof with an acid and the solvates thereof: in which: • R represents a hydrogen or halogen atom; a C 1 -C 4 alkyl group; a carboxyl group or a (C 1 -C 4 )alkoxycarbonyl group, • R1 represents a C 1 -C 10 (hydroxy)alkyl group, optionally interrupted with one or more non-adjacent oxygen atoms or non-adjacent NR′ substituents, substituted by a cationic CAT group, • R2 represents a hydrogen atom or a C 1 -C 4 (hydroxy)alkyl group, • R1 and R2 may form, together with the atom that bears them, a cationic heterocycle with 5 to 8 members, • R′ represents a hydrogen atom or a C 1 -C 4 (hydroxy)alkyl group; • An″ represents an anion or a mixture of anions which are organic or inorganic and cosmetically acceptable.

Claims (87)

1. A cationic meta-phenylenediamine compound of formula (I), acid addition salts thereof, and solvates thereof:

wherein:

R is chosen from a hydrogen or halogen atom; a C 1 -C 4 alkyl group; a carboxyl group, or a (C 1 -C 4 )alkoxycarbonyl group;

R1 is chosen from a C 1 -C 10 (hydroxy)alkyl group, optionally interrupted with one or more non-adjacent oxygen atoms or non-adjacent NR′ substituents, substituted by a cationic CAT group;

R2 is chosen from a hydrogen atom or a C 1 -C 4 (hydroxy)alkyl group;

R1 and R2 may optionally form, together with the atom that bears them, a cationic heterocycle with 5 to 8 members;

R′ is chosen from a hydrogen atom or a C 1 -C 4 (hydroxy)alkyl group; and

An- is chosen from an anion or a mixture of anions which are organic or inorganic and cosmetically acceptable.

2. The compound according to claim 1 , wherein the cationic CAT group is chosen from straight or branched or heterocyclic groups comprising a quaternary ammonium of the type —N + RaRbRc,

wherein Ra, Rb and Rc are independently chosen from a C 1 -C 6 alkyl group which may optionally be substituted by a hydroxyl; and

Ra and Rb may optionally form a 5- to 10-membered heterocycle, in which case Rc is a C 1 -C 6 alkyl group, optionally substituted by a hydroxyl group or a C 1 -C 4 (hydroxy)alkyl group.

3. The compound according to claim 2 , wherein Ra, Rb, Rc independently represent a C 1 -C 2 alkyl group, optionally substituted by a hydroxyl group.

4. The compound according to claim 2 , wherein the cationic CAT group is chosen from trimethylammonium, triethylammonium, dimethylethylammonium, diethylmethylammonium, diisopropylmethylammonium, hydroxyethyldiethylammonium, imidazolium, pyridinium, piperazinium, pyrrolidinium, morpholinium, pyrimidinium, thiazolium, benzimidazolium and piperidinium groups, or mixtures thereof.

5. The compound according to claim 1 , wherein R represents a hydrogen atom.

6. The compound according to claim 1 , wherein R2 represents a hydrogen atom or a C 1 -C 4 alkyl group.

7. The compound according to claim 1 , wherein R1 represents a C 1 -C 10 alkyl group substituted by a cationic CAT group.

8. The compound according to claim 1 , wherein R1 represents a C 1 -C 10 alkyl group interrupted with an oxygen atom or an NR′ substituent, substituted by a cationic CAT group.

9. The compound according to claim 7 , wherein CAT designates a cationic group chosen from trimethylammonium, triethylammonium, dimethylethyl ammonium, diethylmethylammonium, diisopropylmethylammonium, diethylpropyl ammonium, hydroxyethyl diethyl ammonium, di-beta-hydroxyethylmethylammonium, tri-beta-hydroxyethylammonium groups, or mixtures thereof.

10. The compound according to claim 1 , wherein CAT designates a 5- to 8-membered heterocyclic group of which one of the members is a quaternary ammonium,

said heterocycle optionally substituted by one or more groups independently chosen from a hydroxyl group or a C 1 -C 4 (hydroxy)alkyl group.

11. The compound according to claim 10 , wherein CAT designates a pyrrolidine, piperidine, or piperazine group, optionally substituted by a cationic —N + RaRbRc group,

wherein Ra, Rb, Rc are independently chosen from a C 1 -C 6 alkyl group, optionally substituted by a hydroxyl group.

12. The compound according to claim 11 , wherein CAT designates a pyrrolidine or piperidine group, optionally substituted by a tri(C 1 -C 4 )alkyl ammonium group.

13. The compound according to claim 1 , wherein R1 and R2 form, together with the atom that bears them, a cationic 5- to 8-membered heterocycle.

14. The compound according to claim 13 , wherein R1 and R2 form, together with the nitrogen atom that bears them, a 5- to 8-membered heterocyclic group of which one member is a quaternary ammonium, said heterocycle optionally substituted by one or more groups independently chosen from a hydroxyl group or a C 1 -C 4 (hydroxy)alkyl group.

15. The compound according to claim 1 , wherein R1 and R2 form, together with the nitrogen atom that bears them, a pyrrolidine or piperidine group, substituted by a cationic —N + RaRbRc group,

wherein Ra, Rb, Rc are independently chosen from C 1 -C 6 alkyl groups optionally substituted by a hydroxyl group,

said cationic group being chosen from trimethylammonium, triethylammonium, dimethylethyl ammonium, or diethylmethylammonium groups.

16. The compound according to claim 1 , chosen from:

2-[(2,4-diaminophenyl)amino]-N,N,N-trimethylethanaminium, An-,

3-[(2,4-diaminophenyl)amino]-N,N,N-trimethylpropan-1-aminium, An-,

4-{2-[(2-amino-5-hydroxyphenyl)amino]ethyl}-1,1-dimethylpiperazin-1-ium, An-,

4-{3-[(2,4-diaminophenyl)amino]propyl}-1,1-dimethylpiperazin-1-ium, An-,

4-{2-[(2,4-diaminophenyl)amino]ethyl}-1-(2-hydroxyethyl)-1-methylpiperazin-1-ium, An-,

1-{2-[(2,4-diaminophenyl)amino]ethyl}-1-methylpiperidinium, An-,

1-{3-[(2,4-diaminophenyl)amino]propyl}-1-methylpiperidinium, An-,

1-{2-[(2,4-diaminophenyl)amino]ethyl}-1-methylpyrrolidinium, An-,

1-{3-[(2,4-diaminophenyl)amino]propyl}-1-methylpyrrolidinium, An-,

4-{2-[(2,4-diaminophenyl)amino]ethyl}-4-methylmorpholin-4-ium, An-,

4-{3-[(2,4-diaminophenyl)amino]propyl}-4-methylmorpholin-4-ium, An-,

1-{2-[(2,4-diaminophenyl)amino]ethyl}-3-methyl-1H-imidazol-3-ium, An-,

1-{3-[(2,4-diaminophenyl)amino]propyl}-3-methyl-1H-imidazol-3-ium, An-,

2-[(2,4-diaminophenyl)(methyl)amino]-N,N,N-trimethylethanaminium, An-,

3-[(2,4-diaminophenyl)(methyl)amino]-N,N,N-trimethylpropan-1-aminium, An-,

1-{2-[(2,4-diaminophenyl)(methyl)amino]ethyl}-1-methylpyrrolidinium, An-,

1-{3-[(2,4-diaminophenyl)(methyl)amino]propyl}-1-methylpyrrolidinium, An-,

1-{2-[(2,4-diaminophenyl)(methyl)amino]ethyl}-1-methylpiperidinium, An-,

1-{3-[(2,4-diaminophenyl)(methyl)amino]propyl}-1-methylpiperidinium, An-,

4-{2-[(2,4-diaminophenyl)(methyl)amino]ethyl}-4-methylmorpholin-4-ium, An-,

4-{3-[(2,4-diaminophenyl)(methyl)amino]propyl}-4-methylmorpholin-4-ium, An-,

1-(2,4-diaminophenyl)-N,N,N-trimethylpyrrolidin-3-aminium, An-,

4-(2,4-diaminophenyl)-1,1-dimethylpiperazin-1-ium, An-,

4-(2,4-diaminophenyl)-1-(2-hydroxyethyl)-1-methylpiperazin-1-ium, An-,

4-(2,4-diaminophenyl)-1,1-bis(2-hydroxyethyl)piperazin-1-ium, An-,

1-(2,4-diaminophenyl)-N,N,N-trimethylpiperidin-4-aminium, An-,

1-[2-({2-[(2,4-diaminophenyl)amino]ethyl}amino)ethyl]-1-methylpiperidinium, An-,

1-[2-({2-[(2,4-diaminophenyl)amino]ethyl}amino)ethyl]-1-methylpyrrolidinium, An-,

1-[2-({2-[(2,4-diaminophenyl)amino]ethyl}amino)ethyl]-3-methyl-1H-imidazol-3-ium, An-,

4-[2-({2-[(2-amino-5-4-[2-({2-[(2,4-diaminophenyl)amino]ethyl}amino)ethyl]-4-methylmorpholin-4-ium, An-,

3-({2-[(2,4-diaminophenyl)amino]ethyl}amino)-N,N,N-trimethylpropan-1-aminium, An-,

2-{2-[(2,4-diaminophenyl)amino]ethoxy}-N,N,N-trimethylethanaminium, An-,

3-{2-[(2,4-diaminophenyl)amino]ethoxy}-N,N,N-trimethylpropan-1-aminium, An-,

1-(2-{2-[(2,4-diaminophenyl)amino]ethoxy}ethyl)-1-methylpiperidinium, An-,

1-(2-{2-[(2,4-diaminophenyl)amino]ethoxy}ethyl)-1-methylpyrrolidinium, An-,

4-(2-{2-[(2,4-diaminophenyl)amino]ethoxy}ethyl)-1,1-dimethylpiperazin-1-ium, An-,

4-(3-{2-[(2,4-diaminophenyl)amino]ethoxy}propyl)-1,1-dimethylpiperazin-1-ium, An-,

4-(2-{2-[(2,4-diaminophenyl)amino]ethoxy}ethyl)-4-methylmorpholin-4-ium, An-,

4-(3-{2-[(2,4-diaminophenyl)amino]ethoxy}propyl)-4-methylmorpholin-4-ium, An-,

1-(2-{2-[(2,4-diaminophenyl)amino]ethoxy}ethyl)-3-methyl-1H-imidazol-3-ium, An-,

1-(3-{2-[(2,4-diaminophenyl)amino]ethoxy}propyl)-3-methyl-1H-imidazol-3-ium, An-,

and salts, solvates, isomers thereof, and mixtures thereof.

17. A composition for dyeing keratin fibers comprising, in a medium that is suitable for dyeing keratin fibers, at least one compound chosen from cationic meta-phenylenediamine compounds of formula (I), acid addition salts thereof, and solvates thereof:

wherein:

R is chosen from a hydrogen or halogen atom; a C 1 -C 4 alkyl group; a carboxyl group, or a (C 1 -C 4 )alkoxycarbonyl group;

R1 is chosen from a C 1 -C 10 (hydroxy)alkyl group, optionally interrupted with one or more non-adjacent oxygen atoms or non-adjacent NR′ substituents, substituted by a cationic CAT group;

R2 is chosen from a hydrogen atom or a C 1 -C 4 (hydroxy)alkyl group;

R1 and R2 may optionally form, together with the atom that bears them, a cationic heterocycle with 5 to 8 members;

R′ is chosen from a hydrogen atom or a C 1 -C 4 (hydroxy)alkyl group; and

An- is chosen from an anion or a mixture of anions which are organic or inorganic and cosmetically acceptable.

18. A process for dyeing keratin fibers, comprising applying a dyeing composition to said fibers, either alone or in the presence of an oxidizing agent, for a time that is sufficient to develop the desired color, wherein said dyeing composition comprises at least one cationic meta-phenylenediamine compound of formula (I), acid addition salts thereof, and solvates thereof:

wherein:

R is chosen from a hydrogen or halogen atom; a C 1 -C 4 alkyl group; a carboxyl group, or a (C 1 -C 4 )alkoxycarbonyl group;

R1 is chosen from a C 1 -C 10 (hydroxy)alkyl group, optionally interrupted with one or more non-adjacent oxygen atoms or non-adjacent NR′ substituents, substituted by a cationic CAT group;

R2 is chosen from a hydrogen atom or a C 1 -C 4 (hydroxy)alkyl group;

R1 and R2 may optionally form, together with the atom that bears them, a cationic heterocycle with 5 to 8 members;

R′ is chosen from a hydrogen atom or a C 1 -C 4 (hydroxy)alkyl group; and

An- is chosen from an anion or a mixture of anions which are organic or inorganic and cosmetically acceptable.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2014
From: FADLI, AZIZ
To: L'OREAL
Reel/Frame 034596/0904 →
Priority Claims (1)
FR 12 56309 · Jul 2, 2012 · national
Continuity (2)
Provisional Application 61695316 · Aug 31, 2012
Related Publication 20150143638A1 · May 28, 2015